Growth Metrics

Aurinia Pharmaceuticals (AUPH) Amortizatization of Intangibles (2020 - 2025)

Historic Amortizatization of Intangibles for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to $2.6 million.

  • Aurinia Pharmaceuticals' Amortizatization of Intangibles fell 2326.81% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year decrease of 1710.96%. This contributed to the annual value of $12.7 million for FY2024, which is 485.96% up from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Amortizatization of Intangibles of $2.6 million as of Q3 2025, which was down 2326.81% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Amortizatization of Intangibles ranged from a high of $3.4 million in Q3 2024 and a low of -$1.6 million during Q4 2021
  • Over the past 5 years, Aurinia Pharmaceuticals' median Amortizatization of Intangibles value was $2.6 million (recorded in 2023), while the average stood at $1.8 million.
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Amortizatization of Intangibles tumbled by 19365.67% in 2022, and later surged by 162913.91% in 2023.
  • Over the past 5 years, Aurinia Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at -$1.6 million in 2021, then soared by 199.74% to $1.6 million in 2022, then skyrocketed by 112.13% to $3.3 million in 2023, then dropped by 9.86% to $3.0 million in 2024, then fell by 11.88% to $2.6 million in 2025.
  • Its Amortizatization of Intangibles stands at $2.6 million for Q3 2025, versus $2.6 million for Q2 2025 and $2.7 million for Q1 2025.